@article{ebce7356404a4de58f3a9841cd2a8dd8,
title = "The spectrum of bleeding in women and girls with haemophilia B",
abstract = "Although hemophilia B affects 1 in 25,000 males there may be 3 female hemophilia B carriers per affected male. This clinical review highlights the unique challenges faced by hemophilia B carriers including the under-recognition of bleeding symptoms associated with and without FIX deficiency, discrepancies in correlation between genotype and bleeding phenotype and therapeutic considerations utilizing clinical vignettes of common scenarios.",
keywords = "haemophilia, haemophilia carriers, review, women with bleeding disorders",
author = "J. Staber and Croteau, {S. E.} and J. Davis and Grabowski, {E. F.} and P. Kouides and Sidonio, {R. F.}",
note = "Funding Information: and Pfizer and has contracted research with Pfizer. JD has served as an advisor for CSL Behring, Novo Nordisk, Bayer, Shire, Genentech, Octapharma and Bioverativ. JD is a speaker for Bioverativ and Shire. EG has served as an advisor for Aptevo Therapeutics. PK has served an advisor and has contracted research for Faust Pharmaceuticals. RFS has served an advisor for Aptevo Therapeutics, LFB, Bioverativ, Pfizer, Bayer and Novo Nordisk. RFS has investigator initiated grants from Bioverativ and Shire. Apteveo paid for medical writing assistance but had no editorial authority in this manuscript. Publisher Copyright: 2017 The Authors. Haemophilia Published by John Wiley & Sons Ltd",
year = "2018",
month = mar,
doi = "10.1111/hae.13376",
language = "English (US)",
volume = "24",
pages = "180--185",
journal = "Haemophilia",
issn = "1351-8216",
publisher = "Wiley-Blackwell",
number = "2",
}